[Mesenchyma-suppressing therapy of chronic aggressive hepatitis].
D000293:Adolescent; D000328:Adult; D000368:Aged; D001706:Biopsy; D002908:Chronic Disease; D004342:Drug Hypersensitivity; D005076:Exanthema / Q000139:chemically induced; D005260:Female; D005882:Gingival Diseases / Q000139:chemically induced; D006505:Hepatitis / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D008103:Liver Cirrhosis / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D010396:Penicillamine / Q000009:adverse effects / Q000627:therapeutic use*; D011736:Pyridoxine / Q000627:therapeutic use
D010396:Penicillamine; D011736:Pyridoxine
Zur mesenchymsuppressiven Therapie der chronisch-aggressiven Hepatitis.